Skip to main content
. 2018 Sep 16;26(4):571–578. doi: 10.5606/tgkdc.dergisi.2018.16049

Table 2. Graft use for treatment.

  No treatment Tigecycline Mesenchymal stem cell p
    Median Interquartile range Median Interquartile range  
No Dacron graft implanted 9.6 (5.3-8.2)x107 0 0-0 0 0-0 <0.001*
Dacron graft implanted - 81 73-86 109 93-121 0.004**
The Kruskal-Wallis test median (25-75%); * Difference between treatments in the no graft implantation groups; ** Difference between treatments in the Dacron graft implantation groups.